Charme IV makes its fifth investment with Tema Sinergie
Tema Sinergie produces isolators for nuclear medicine and the production of biotech pharmaceuticals.
28 October 2022•1 min read
Tema Sinergie produces isolators for nuclear medicine and the production of biotech pharmaceuticals.
Rubicon Technology Partners’ Procede Software acquires dealer software firm RIMSS
3 minutes ago · 2 mins read
Oridian Capital-backed ACR picks up Ultra Green Packaging in 12th add-on
7 minutes ago · 2 mins read
Inflexion agrees sale of majority Celnor stake to Goldman Sachs Alternatives
3 hours ago · 2 mins read
Kohlberg-backed Trinity acquires Verix to add pharma AI execution tools
16 hours ago · 2 mins read
Brenton Point-backed Landmark Funeral Group agrees majority investment in Funeral Excellence Group
16 hours ago · 1 min read
LLCP completes sale of Global Loan Agency Services to Oakley Capital
19 hours ago · 1 min read
Vinci Compass agrees deal for Latin American reinsurer AustralRe
20 hours ago · 2 mins read
